Skip to main content

Thermo Fisher Scientific Organic revenue (change on a year)

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

Organic revenue (change on a year) at Thermo Fisher Scientific came to 6% for the quarter to 26 Sep 2026, up 3.0 points from a year earlier.

As Thermo Fisher Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 21 Oct 2026.

By quarter

−8%Apr 2023−3%Jul 2023−3%Sep 2023−4%Mar 2024−1%Jun 20240%Sep 20241%Mar 20252%Jun 20253%Sep 20251%Mar 20265%Jun 20266%Sep 2026
Thermo Fisher Scientific Organic revenue (change on a year), every reported period
Period endingOrganic revenue (change on a year)Change on a yearFiled
26 Sep 20266%up 3.0 points21 Oct 2026
27 Jun 20265%up 3.0 points23 Jul 2026
28 Mar 20261%unchanged23 Apr 2026
27 Sep 20253%up 3.0 points22 Oct 2025
28 Jun 20252%up 3.0 points23 Jul 2025
29 Mar 20251%up 5.0 points23 Apr 2025
28 Sep 20240%up 3.0 points1 Nov 2024
29 Jun 2024−1%up 2.0 points2 Aug 2024
30 Mar 2024−4%up 4.0 points3 May 2024
30 Sep 2023−3%down 2.0 points3 Nov 2023
1 Jul 2023−3%down 6.0 points4 Aug 2023
1 Apr 2023−8%down 11.0 points5 May 2023
1 Oct 2022−1%—4 Nov 2022
2 Jul 20223%—5 Aug 2022
2 Apr 20223%—6 May 2022

Definition

Revenue from this part of the business, as the company names and reports it in its results. Shown as the change on the same period a year earlier, as the company prints it. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Thermo Fisher Scientific: Remaining performance obligations · Product revenues · Service revenues · Consumables revenue · Instruments revenue · Clinical research revenue · Research and safety market channel revenue · Pharma services revenue · Biosciences revenue · BioProduction revenue · Chromatography and mass spectrometry revenue · Electron microscopy revenue · Genetic sciences revenue · Laboratory products revenue · Healthcare market channel revenue · Chemical analysis revenue · Clinical diagnostics revenue · ImmunoDiagnostics revenue · Transplant diagnostics revenue · Microbiology revenue · Laboratory Products and Biopharma Services revenue · Life Sciences Solutions revenue · Analytical Instruments revenue · Specialty Diagnostics revenue · financial statements

Every KPI and segment of TMO, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.